This filing details the significant year-to-date stock declines for Oklo and NuScale, attributing the slump to their pre-revenue status, substantial share dilution, and ongoing SMR risks. The declines have resulted in substantial gains for short sellers, indicating a bearish sentiment on these companies' near-term prospects.
Oklo and NuScale, key players in the Small Modular Reactor (SMR) space, have seen their stock prices plummet by 49% and 43% respectively this year. This decline is primarily driven by their pre-revenue status, heavy reliance on R&D, and significant share dilution to fund operations, as evidenced by recent large share offerings. Short sellers have capitalized on this weakness, accumulating substantial gains, which highlights the market's skepticism regarding the companies' profitability timelines and the inherent risks of SMR technology, including a shortage of high-assay low-enriched uranium. While the long-term potential of SMRs in the AI boom remains, the short-term outlook for these stocks is bearish, with continued dilution and market markdown phases expected, though the risk of a short squeeze always looms.